Combination therapy for chronic hepatitis C is associated with adverse effects that can lead to dose reduction or even discontinuation of treatment. A prospective, real-time, observational study by Marcellin and colleagues provides useful information for physicians regarding the role of patient adherence in tailoring patient management and optimizing treatment outcomes.

Comment on Liver Int. 2011 Apr;31(4):516-24.